Crosstalk Between Epidermal Growth Factor Receptor- and Insulin-Like Growth Factor-1 Receptor Signaling: Implications for Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|9|6|748-760

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.9, Iss.6, 2009-09, pp. : 748-760

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The insulin-like growth factor-I receptor as a target for cancer therapy

By Baserga Renato  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 753-768

Informa Healthcare

Access to resources Recommend Favorite

Targeting the type 1 insulin-like growth factor receptor as a treatment for cancer

By Yuen John SP   Macaulay Valentine M  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 5, 2008-05 ,pp. : 589-603

Informa Healthcare

Access to resources Recommend Favorite

Insulin-like Growth Factor-1 Receptor (IGF-1R) Kinase Inhibitors in Cancer Therapy: Advances and Perspectives

By  

Current Pharmaceutical Design, Vol. 18, Iss. 20, 2012-07 ,pp. : 2901-2913

Bentham Science Publishers

Access to resources Recommend Favorite

Involvement of insulin-like growth factor 1 receptor transactivation in endothelin-1-induced signaling in vascular smooth muscle cells

By Bouallegue Ali   Vardatsikos George   Srivastava Ashok K.  

Canadian Journal of Physiology and Pharmacology, Vol. 88, Iss. 5, 2010-05 ,pp. : 501-509

NRC Research Press

Access to resources Recommend Favorite

Insulin-Like Growth Factor Receptor-1 as an Anti-Cancer Target: Blocking Transformation and Inducing Apoptosis

By  

Current Cancer Drug Targets, Vol. 2, Iss. 3, 2002-09 ,pp. : 191-207

Bentham Science Publishers

Access to resources Recommend Favorite